Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Ollie's Bargain Outlet
OLLI
$4.4B
| $24M | 0.02% |
511,778
-187,742
| -27% | -$10.1M |
|
|
MRTX
527
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $23.9M | 0.02% |
527,709
-924,507
| -64% | -$59.8M |
|
528
Alphatec Holdings
ATEC
$1.49B
| $23.9M | 0.02% |
1,935,608
-1,935,610
| -50% | -$19.5M |
|
529
Franklin FTSE Japan ETF
FLJP
$4.01B
| $23.9M | 0.02% |
+994,365
| New | +$23.2M |
|
530
FLEX LNG
FLNG
$1.68B
| $23.9M | 0.02% |
732,940
-1,282,226
| -64% | -$42.9M |
|
531
Novanta
NOVT
$4.95B
| $23.8M | 0.02% |
175,319
-201,245
| -53% | -$28.2M |
|
532
OmniAb
OABI
$288M
| $23.7M | 0.02% |
+6,582,201
| New | +$34.5M |
|
|
GTLS.PRB
533
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $23.6M | 0.02% |
+468,000
| New | +$23.1M |
|
|
SAGE
534
DELISTED
Sage Therapeutics
SAGE
| $23.6M | 0.02% |
619,290
-843,556
| -58% | -$32.2M |
|
535
Autoliv
ALV
$9.09B
| $23.6M | 0.02% |
308,379
-479,371
| -61% | -$38.3M |
|
536
Watts Water Technologies
WTS
$11.5B
| $23.5M | 0.02% |
161,044
-161,868
| -50% | -$23.3M |
|
|
NUVA
537
DELISTED
NuVasive, Inc.
NUVA
| $23.5M | 0.02% |
570,920
+550,042
| +2,635% | +$22.3M |
|
538
BioCryst Pharmaceuticals
BCRX
$2.35B
| $23.5M | 0.02% |
2,050,026
+1,978,070
| +2,749% | +$24.7M |
|
539
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.78B
| $23.5M | 0.02% |
+479,165
| New | +$22.2M |
|
540
Janus International
JBI
$694M
| $23.4M | 0.02% |
2,457,640
-2,457,638
| -50% | -$23.7M |
|
541
Westlake Corp
WLK
$9.19B
| $23.3M | 0.02% |
227,575
-371,671
| -62% | -$37.4M |
|
542
Evertec
EVTC
$1.95B
| $23.3M | 0.02% |
720,541
-557,985
| -44% | -$18.3M |
|
543
Biomea Fusion
BMEA
$88.2M
| $23.2M | 0.02% |
2,757,108
-2,905,868
| -51% | -$24.8M |
|
544
Diodes
DIOD
$3.77B
| $23M | 0.02% |
301,977
-375,733
| -55% | -$29.4M |
|
545
Arrowhead Research
ARWR
$12.3B
| $23M | 0.02% |
565,908
-572,558
| -50% | -$19M |
|
546
BILL Holdings
BILL
$4.52B
| $22.8M | 0.02% |
209,488
-184,116
| -47% | -$22.1M |
|
547
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $22.7M | 0.02% |
293,092
+209,866
| +252% | +$16.1M |
|
|
DOOR
548
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $22.6M | 0.02% |
280,350
-239,422
| -46% | -$17.7M |
|
549
Neogen
NEOG
$2.51B
| $22.6M | 0.02% |
1,482,612
-1,489,906
| -50% | -$21.2M |
|
550
First Busey Corp
BUSE
$2.6B
| $22.4M | 0.02% |
907,700
-795,402
| -47% | -$19.9M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.